Cancer Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ARGX | D | argenx SE | 1.14 | |
ZYME | F | Zymeworks Inc. | 1.85 | |
XLO | C | Xilio Therapeutics, Inc. | 7.92 | |
HOWL | B | Werewolf Therapeutics, Inc. | 8.70 | |
THAR | F | Tharimmune, Inc. | 2.22 | |
TCBP | C | TC BioPharm (Holdings) plc | -2.55 | |
SNTI | F | Senti Biosciences, Inc. | 4.05 | |
SNSE | B | Sensei Biotherapeutics, Inc. | 1.99 | |
PDSB | F | PDS Biotechnology Corporation | 0.31 | |
NBTX | D | Nanobiotix S.A. | -2.88 |
Related Industries: Biotechnology Shell Companies
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 4.02 | |
CNCR | D | Loncar Cancer Immunotherapy ETF | 2.89 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 1.6 | |
PTH | D | Invesco DWA Healthcare Momentum ETF | 1.54 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 0.86 |
Compare ETFs
- Cancer Immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles